BioMarin Pharmaceutical Company Profile

07:10 EDT 23rd September 2017 | BioPortfolio

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that:

* Address currently unmet medical needs

* Suggest a clear-cut development profile

* Provide an opportunity to be first-to-market

The company's product portfolio is comprised of three approved products and multiple investigational product candidates. [link to Preclinical product chart: 3.1] FDA-approved products include Kuvan® (sapropterin dihydrochloride) tablets for PKU, an oral small molecule therapeutic developed in partnership with Merck Serono; Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; and Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation. Investigational product candidates include PEG-PAL for the treatment of phenylketonuria (PKU), and 6R-BH4, currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease.


105 Digital Drive
United States of America


Phone: 415 884 6700
Fax: 415 832 7889

News Articles [573 Associated News Articles listed on BioPortfolio]

BioMarin to Attend Upcoming Investor Conference

SAN RAFAEL, Calif., May 31, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Dan Spiegelman, Executive Vice President and Chief Financial Officer, will parti...

BioMarin to Attend Upcoming Investor Conferences

SAN RAFAEL, Calif., Aug. 15, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's Annual Biotech Conference on September 6,...

Deals this week: BioMarin Pharmaceutical, Spectrum Pharmaceuticals, Orient Pharma

US-based biotechnology company BioMarin Pharmaceutical has announced the completion of an underwritten public offering of senior subordinated convertible notes to raise $450m.

BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance ReportSummaryBioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and...

BioMarin files BLA of phenylketonuria drug to FDA

A biologics license application has been filed by BioMarin Pharmaceutical for pegvaliase, indicated to treat patients with ph -More- 

BioMarin's CLN2 disease drug gets EC nod

The European Commission has granted approval to BioMarin Pharmaceutical's Brineura as a treatment for patients with neuronal  -More- 

BioMarin to Host Second Quarter 2017 Financial Results Conference Call and Webcast on Wednesday, August 2 at 4:30pm ET

SAN RAFAEL, Calif., July 18, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will h...

Sarepta, BioMarin Settle Exon Skipping Patent Dispute

Sarepta Therapeutics will license global exclusive rights to BioMarin Pharmaceutical’s patent estate for the marketed Duchenne muscular dystrophy (DMD) treatment Exondys 51™ (eteplirsen) and all f...

PubMed Articles [482 Associated PubMed Articles listed on BioPortfolio]

Critical review of surface-enhanced Raman spectroscopy applications in the pharmaceutical field.

Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.

Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...

Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?

Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative medicines. Pharmaceutical co-crystals, formed by an active pharmaceutical substance (API) and a co-crys...

Prioritization of diseases for the development of a pharmaceutical care service model in South Korea using the analytic hierarchy process

Drug therapy plays a critical role in most chronic diseases. Effectiveness of pharmaceutical care services in the improvement of clinical, social, or economic outcomes has been scientifically proven t...

A randomized controlled trial of the impact of pharmacist-led patient-centered pharmaceutical care on patients' medicine therapy-related quality of life.

Due to a lack of pharmaceutical care (PC)-specific measures for health-related quality of life, a novel generic questionnaire "Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality o...

Clinical Trials [262 Associated Clinical Trials listed on BioPortfolio]

Gene Therapy Study in Severe Haemophilia A Patients

This study is being conducted by Biomarin Pharmaceutical Inc. as an open label, dose escalation study in order to determine the safety and efficacy of BMN 270 (an Adenovirus-Associated Vir...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [1001 Associated Companies listed on BioPortfolio]

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that: * Address currently unmet medical needs * ...

BioMarin Pharmaceutical Inc.

IBEX Technologies Incorporated

IBEX Technologies is based in Montreal in a 20,000 square foot facility, comprising of small-scale fermentation facilities, general laboratories and offices.IBEX has historically been focused on the d...

Raptor Pharmaceutical

Raptor Pharmaceutical Inc. is the culmination of years of experience and research by a consortium of scientists, investors, and creative minds with one common goal, the development of novel protein th...

More Information about "BioMarin Pharmaceutical" on BioPortfolio

We have published hundreds of BioMarin Pharmaceutical news stories on BioPortfolio along with dozens of BioMarin Pharmaceutical Clinical Trials and PubMed Articles about BioMarin Pharmaceutical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMarin Pharmaceutical Companies in our database. You can also find out about relevant BioMarin Pharmaceutical Drugs and Medications on this site too.

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record